These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27097498)

  • 61. Pathophysiology of Liver Fibrosis.
    Pinzani M
    Dig Dis; 2015; 33(4):492-7. PubMed ID: 26159264
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission.
    Maia JM; Maranhão Hde S; Sena LV; Rocha LR; Medeiros IA; Ramos AM
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):264-9. PubMed ID: 20009940
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatic macrophages: Key players in the development and progression of liver fibrosis.
    Cheng D; Chai J; Wang H; Fu L; Peng S; Ni X
    Liver Int; 2021 Oct; 41(10):2279-2294. PubMed ID: 33966318
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immune interactions in hepatic fibrosis.
    Holt AP; Salmon M; Buckley CD; Adams DH
    Clin Liver Dis; 2008 Nov; 12(4):861-82, x. PubMed ID: 18984471
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preliminar evaluation of cytokines in the hepatitis C-schistosomiasis co-infection.
    Morais CN; Carvalho BM; Melo WG; Lopes EP; Domingues AL; Jucá NT; Souza W; Abath FG; Montenegro SM
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():353-4. PubMed ID: 17308796
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis.
    Ramachandran P; Matchett KP; Dobie R; Wilson-Kanamori JR; Henderson NC
    Nat Rev Gastroenterol Hepatol; 2020 Aug; 17(8):457-472. PubMed ID: 32483353
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The versatility of macrophage heterogeneity in liver fibrosis.
    Gao CC; Bai J; Han H; Qin HY
    Front Immunol; 2022; 13():968879. PubMed ID: 35990625
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The role of activated hepatic stellate cells in liver fibrosis, portal hypertension and cancer angiogenesis].
    Lee JS; Kim JH
    Korean J Hepatol; 2007 Sep; 13(3):309-19. PubMed ID: 17898548
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Liver fibrosis and repair: immune regulation of wound healing in a solid organ.
    Pellicoro A; Ramachandran P; Iredale JP; Fallowfield JA
    Nat Rev Immunol; 2014 Mar; 14(3):181-94. PubMed ID: 24566915
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RIP3 deficiency attenuated hepatic stellate cell activation and liver fibrosis in schistosomiasis through JNK-cJUN/Egr1 downregulation.
    Song LJ; Yin XR; Guan SW; Gao H; Dong PP; Mei CJ; Yang YY; Zhang Y; Yu CX; Hua ZC
    Signal Transduct Target Ther; 2022 Jun; 7(1):193. PubMed ID: 35754047
    [No Abstract]   [Full Text] [Related]  

  • 71. Liver fibrosis and inflammation. A review.
    Kershenobich Stalnikowitz D; Weissbrod AB
    Ann Hepatol; 2003; 2(4):159-63. PubMed ID: 15115954
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Portal venous pressure in "pipestem" fibrosis of the liver due to schistosomiasis.
    AUFSES AH; SCHAFFNER F; ROSENTHAL WS; HERMAN BE
    Am J Med; 1959 Nov; 27():807-10. PubMed ID: 13795097
    [No Abstract]   [Full Text] [Related]  

  • 73. Pathology of liver cirrhosis in experimental schistosomiasis japonica.
    Tsutsumi H
    Acta Pathol Jpn; 1971 May; 21(2):243-55. PubMed ID: 5109883
    [No Abstract]   [Full Text] [Related]  

  • 74. Macrophages in the Aging Liver and Age-Related Liver Disease.
    Stahl EC; Haschak MJ; Popovic B; Brown BN
    Front Immunol; 2018; 9():2795. PubMed ID: 30555477
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Parathyroid function in bilharzial (schistomasial) hepatic fibrosis.
    Ghanem MH; Guirgis FK; el-Sawy M
    J Trop Med Hyg; 1970 May; 73(5):126-31. PubMed ID: 4317885
    [No Abstract]   [Full Text] [Related]  

  • 76. IL-13 Signaling in Liver Fibrogenesis.
    Liu Y; Munker S; Müllenbach R; Weng HL
    Front Immunol; 2012; 3():116. PubMed ID: 22593760
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeted therapy of liver fibrosis/cirrhosis and its complications.
    Poelstra K; Schuppan D
    J Hepatol; 2011 Sep; 55(3):726-728. PubMed ID: 21601600
    [No Abstract]   [Full Text] [Related]  

  • 78. Is cirrhosis of the liver reversible?
    Kumar M; Sarin SK
    Indian J Pediatr; 2007 Apr; 74(4):393-9. PubMed ID: 17476087
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities.
    Binatti E; Gerussi A; Barisani D; Invernizzi P
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743092
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oxidative stress: does it 'initiate' hepatic stellate cell activation or only 'perpetuate' the process?
    Apte M
    J Gastroenterol Hepatol; 2002 Oct; 17(10):1045-8. PubMed ID: 12201862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.